Covid-19 In Tunisia: An Observational Cross-Sectional Registry Study

Covid 19 Clinical Trial

— CONNAITRE  

Official title:

Covid-19 In Tunisia: An Observational Cross-Sectional Registry Study Multicentric Study

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT04384614
• Other study ID #: ECC2020-07
• Status: Withdrawn
• Start date: May 15, 2020
• Est. completion date: July 15, 2020

Study information

• Verified date: May 2020
• Source: Direction des Soins de Santé de Base
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

Covid-19 In Tunisia: AN Observational Cross-Sectional Registry Study

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: July 15, 2020
• Est. primary completion date: July 15, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

• COVID-19 (+), inpatient or outpatient, confirmed by PCR test

• COVID-19 (-) confirmed by PCR test having been in contact with COVID-19 (+)

Exclusion Criteria:

• COVID(+) and COVID(-) diagnosed by other tests than PCR

• COVID-19 (-) Not having been in contact with COVID19(+)

Related Conditions & MeSH terms

• BCG Vaccination
• Covid 19

Intervention

Diagnostic Test:
• Test PCR
Viral load (COVID+) testing by PCR

Genetic:
• TDR
IDR and blood sampling for testing DNA Cheque

Other:
• Clinical Examination
COVID 19 symptoms and Physical Examination

Locations

Country	Name	City	State
Tunisia	Eshmoun Clinical Research Centre	Tunis

Sponsors (3)

Lead Sponsor	Collaborator
Direction des Soins de Santé de Base	Dacima Consulting, Eshmoun Clinical Research Centre

Country where clinical trial is conducted

Tunisia, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Differences related to epidemiological demographic characteristics	Identify differences related to epidemiological demographic characteristics and the profile of COVID(+) vs. the profile of COVID(-) patients who have been in contact with COVID(+); Vaccination History Questionnaire; Medical and Surgical History Questionnaire; Clinical Examination; TDR and blood sampling for DNA Checks	30 days